Comparison of LAMP, GeneXpert, Mycobacterial Culture, Smear Microscopy, TSPOT.TB, TBAg/PHA Ratio for Diagnosis of Pulmonary Tuberculosis

Abstract

Objective

To investigate the application value of loop-mediated isothermal amplification (LAMP), GeneXpert, mycobacterial culture, smear microscopy, TSPOT.TB (TSPOT), ratio of TB-specific antigen to phytohemagglutinin (TBAg/PHA ratio) in the detection of mycobacterium tuberculosis in the bronchoalveolar lavage fluid.

Methods

A retrospective analysis was performed on the patients who underwent bronchoscopy from December 2018 to November 2019 in Tongji Hospital. The patients with positive tuberculosis culture or positive GeneXpert in bronchoalveolar lavage fluid were selected as the case group, and those without tuberculosis served as the control group. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of LAMP, GeneXpert, culture, smear microscopy, TSPOT, and TBAg/PHA ratio.

Results

For the patients with positive cultures as case, the sensitivity of LAMP, GeneXpert, smear microscopy, TSPOT and TBAg/PHA ratio was 73.49%, 89.16%, 25.30%, 80.00%, 33.85%, respectively, the specificity was 99.00%, 100.00%, 99.00%, 86.00%, 100.00%, respectively, the area under the ROC curve (AUC) was 0.849, 0.938, 0.633, 0.830, 0.669, respectively. For the patients with positive GeneXpert as case, the sensitivity of LAMP, mycobacterial culture, smear microscopy, TSPOT and TBAg/PHA ratio was 73.20%, 74.23%, 22.68%, 68.92%, 29.73%, respectively, the specificity was 99.00%, 100.00%, 99.00%, 86.00%, 100.00%, respectively, the AUC was 0.853, 0.878, 0.623, 0.775, 0.649, respectively.

Conclusion

The sensitivity of GeneXpert was best. The sensitivity and diagnostic value of LAMP were slightly lower than those of GeneXpert, and were similar to tuberculosis culture. The sensitivity of smear microscopy was low. The specificity of TSPOT was low. When TBAg/PHA ratio >0.2 was used as a diagnostic index, the specificity was improved, but the sensitivity was low.

References

[1] World Health Organization(2019)Global tuberculosis report 2019, 2019, Geneva, WHO[Accessed 30 June 2021]

[2] World Health Organization(2018)Global tuberculosis report 2018, 2018, Geneva, WHO[Accessed 30 June 2021]

[3] PangY, DuJ, QinZZ, et al.. An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey. Eur Respir J, 2016, 47(5): 1584-1587

[4] LawnSD, NicolMP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol, 2011, 6(9): 1067-1082

[5] NotomiT, OkayamaH, MasubuchiH, et al.. Loopmediated isothermal amplification of DNA. Nucleic Acids Res, 2000, 28(12): E63

[6] RudeeaneksinJ, BunchooS, SrisungngamS, et al.. Rapid identification of Mycobacterium tuberculosis in BACTEC MGIT960 cultures by in-house loop-medicated isothermal amplification. Jpn J Infect Dis, 2012, 65(4): 306-311

[7] OuX, LiQ, XiaH, et al.. Diagnostic accuracy of the PURE-LAMP test for pulmonary tuberculosis at the county-level laboratory in China. PLoS One, 2014, 9(5): e94544

[8] NeonakisIK, SpandidosDA, PetinakiE. Use of loopmediated isothermal amplification of DNA for the rapid detection of Mycobacterium tuberculosis in clinical specimens. Eur J Clin Microbiol Infect Dis, 2011, 30(8): 937-942

[9] WangS, ZhangWH. New progress on diagnosis of tuberculosis. J Microbes Infect, 2016, 11(3): 188-192

[10] WangF, HouHY, WuSJ, et al.. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area. Int J Tuberc Lung Dis, 2016, 20(4): 487-493

[11] WangT, TanYJ, WuSJ, et al.. The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis. Chin J Tuberc Respir Dis, 2019, 42(4): 262-267

[12] National Health and Family Planning Commission of the People’s Republic of ChinaDiagnosis for pulmonary tuberculosis, 2017, WS, The health industry standard of the People’s Republic of China: 288-2017[Accessed 30 June 2021]

[13] SongQZ, LiH, ShaoH, et al.. MicmRNA-365 in macrophages regulates mycobacterium-induced active pulmonary tuberculosis via inteleukin-6. Int J Clin Exp Med, 2015, 8(9): 15 458-15 465

[14] BodalVK, BalMS, BhagatS, et al.. Fluorescent microscopy and Ziehl-Neelson staining of brochoalveolar lavage, bronchial washings, brochoscpic brushing and post bronchoscopic sputum along with cytological examination in cases of suspectec tuberculosis. Indial J Pathol Microbiol, 2015, 58(4): 443-447

[15] SteingartKR, HenryM, NgV, et al.. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis, 2006, 6: 570e81

[16] XuP, TangP, SongHF, et al.. The incremental value of bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in a high-burden urban setting. J Infect, 2019, 79(1): 24-29

[17] LiuX, HouXF, GaoL, et al.. Indicators for prediction of Mycobacterium tuberculosis positivity detected with bronchoalveolar lavage fluid. Infect Dis Poverty, 2018, 7(1): 22

[18] World Health Organization(2013)Automated realtime nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy Update, 2013, Geneva, WHO[Accessed 30 June 2021]

[19] BoehmeCC, NabetaP, HillemannD, et al.. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010, 363(11): 1005-1015

[20] Steingart KR, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev, 2013, (1):CD009593

[21] BoehmeCC, NicolMP, NabetaP, et al.. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet, 2011, 377(9776): 1495-1505

[22] LeeHY, SeongMW, ParkSS, et al.. Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosi. Int J Tuberc Lung Dis, 2013, 17(7): 917-921

[23] PanX, YangS, DeightonMA, et al.. A Comprehensive Evaluation of Xpert MTB/RIF Assay with Bronchoalveolar Lavage Fluid as a Single Test or Combined with Conventional Assays for Diagnosis of Pulmonary Tuberculosis in China: A Two-Center Prospective Study. Front Microbiol, 2018, 9: 444

[24] BoehmeCC, NabetaP, HenostrozaG, et al.. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol, 2007, 45(6): 1936-1940

[25] BojangAL, MendyFS, TientcheuLD, et al.. Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in The Gambia. J Infect, 2016, 72(3): 332-337

[26] ShetePB, FarrK, StrnadL, et al.. Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis. BMC Infect Dis, 2019, 19(1): 268

[27] WangH, LiuQX, ChenL, et al.. Evaluation of LAMP method in detecting BALF specimens from patients clinically diagnosed with pulmonary tuberculosis. Int J Lab Med, 2019, 40(7): 783-786

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology